Porcine Vaccines Market Astonishing Growth with Top Influencing Key players
Additionally, rising number of biotechnology companies,
research institutions engaged in research and development of porcine vaccines,
and government initiatives for funding agriculture and animal husbandry sector
and increasing demand for porcine meat and gelatine are likely to contribute to
the market growth. For instance, by the world by per-capita pig meat
consumption, US has an average of 64.4 kilos of meat consumed in 2017.
According to National Pork Producers Council the pork production has an
estimated USD 23.4 billion of gross output nationwide. However, high cost of
maintaining vaccines may hamper the market growth during the assessment period.
The global porcine
vaccines market held a market value of USD 1910.7 million in 2017 and is
projected to grow at a CAGR of 7.1% over the forecast period. Porcine vaccines
aid the swine or hogs suffering from epidemic swine diseases. It also helps in
improving overall efficiency in protecting swine from deadly viruses, bacteria
and increases the production level of high-quality meat and gelatine. The
increasing prevalence of swine diseases such as PED (Porcine Epidemic
Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), swine
influenza etc. are anticipated to drive the market growth during the forecast
period.
Request
Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7438
Key Players
Some of the prominent players in the global porcine vaccines
market are Bayer AG, Bimeda, Inc., Boehringer Ingelheim International GmbH,
Ceva Sante Animale, Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A.,
Vetoquinol S.A., Zoetis, Inc., PBS Animal Health, Aptimmune.
Segmentation
The global porcine vaccines market has been segmented into
type, disease indication, and end user.
By type, the market has been segmented into Inactivated
vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines,
Conjugate vaccines, DNA vaccines.
On the basis of disease indication, the global porcine
vaccines market has been segmented into PED (Porcine Epidemic Diarrhea), PRRS
(Porcine Reproductive & Respiratory Syndrome), Swine influenza, Aujeszky's
disease (AD), Porcine Circovirus Associated Disease (PCVAD) and others.
The global porcine vaccines market, by end user, has been
segmented into Veterinary Hospitals and Hog Production Farm.
Regional Analysis
On regional basis, the Americas is anticipated to dominate
the global porcine vaccines market owing to the increasing prevalence of
porcine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive
& Respiratory Syndrome), swine influenza etc. and rapid increase in pig
farms. Additionally, rise in number of
contract farming and independent farming for pig cultivation is contributing
the market growth. According to The United States Department of Agriculture,
National Agricultural Statistics Service “Livestock Slaughter” report, U.S.
pork production was around 2 billion pound in 2016. Europe is expected to hold
the second largest position in the global porcine vaccines market owing to
increasing number of production units for pigs and high consumption of pork
meat. The Asia-Pacific region is anticipated to be fastest growing region is
due to introduction of new vaccines, initiatives by various government
agencies, animal care associations, and incidence of major key players for
growth and development in this region. The Middle East & Africa has the
least share of the global porcine vaccines market. Moreover, the major market
share of the region is expected to be held by the Middle East region owing to
the increasing government initiatives for the agriculture and animal husbandry
sector.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/porcine-vaccines-market-7438
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment